Stocks and Investing Stocks and Investing
Thu, April 28, 2022
[ 12:00 AM ] - WOPRAI
Laurie Havener Downgraded (CLBK) to Hold on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (CHE) at Buy with Increased Target to $592 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Gabriela Borges Initiated (CCCS) at Hold and Held Target at $11 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (CCK) at Buy with Increased Target to $143 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (SRDX) at Strong Buy with Decreased Target to $46 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Levine Maintained (SRE) at Hold with Increased Target to $86 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Justin Patterson Maintained (SPOT) at Buy with Decreased Target to $210 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Wlodarczak Downgraded (SPOT) to Hold and Held Target at $110 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Barton Crockett Maintained (SPOT) at Hold with Decreased Target to $101 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Steven Cahall Maintained (SPOT) at Sell with Decreased Target to $101 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Mario Lu Maintained (SPOT) at Buy with Decreased Target to $170 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ned Baramov Maintained (SPH) at Hold with Increased Target to $19 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Robin Garner Initiated (XERS) at Strong Buy and Held Target at $6.5 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Cai Rumohr Maintained (TXT) at Buy and Held Target at $95 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Peter Arment Maintained (TXT) at Buy and Held Target at $86 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (TYL) at Buy and Held Target at $600 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Bernie McTernan Maintained (UPWK) at Strong Buy with Decreased Target to $33 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
David Long Maintained (UMBF) at Buy with Decreased Target to $113 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Jared Shaw Maintained (UMBF) at Hold with Decreased Target to $100 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Baxter Maintained (UHS) at Sell with Decreased Target to $118 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Quinn Bolton Maintained (UCTT) at Strong Buy with Decreased Target to $45 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ned Baramov Maintained (WES) at Buy with Increased Target to $33 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Scott Group Upgraded (WAB) to Hold on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Praneeth Satish Maintained (WMB) at Buy with Increased Target to $38 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Kyle White Maintained (WM) at Hold with Increased Target to $167 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Michael Rose Maintained (VBTX) at Strong Buy with Decreased Target to $43 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Sharon Zackfia Downgraded (VRM) to Hold on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Thomas Smith Maintained (VKTX) at Buy with Decreased Target to $12 on, Apr 28th, 2022
Wed, April 27, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (VTR) at Strong Buy with Increased Target to $67 on, Apr 27th, 2022
[ 12:00 AM ] - WOPRAI
Andrea Tan Initiated (VOR) at Hold and Held Target at $6 on, Apr 27th, 2022

Andrea Tan Initiated (VOR) at Hold and Held Target at $6 on, Apr 27th, 2022


Published on 2024-10-27 20:41:20 - WOPRAI, Andrea Tan
  Print publication without navigation


Andrea Tan of Goldman Sachs, Initiated "Vor Biopharma Inc." (VOR) at Hold and Held Target at $6 on, Apr 27th, 2022.

Andrea has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Andrea's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrea

  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $26 on, Monday, March 21st, 2022
  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $30 on, Wednesday, March 16th, 2022
Contributing Sources